advertisement

---

Kolko M 10

Showing records 1 to 10 | Display all abstracts from Kolko M

104340 Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension
Clement Freiberg J
Cochrane Database of Systematic Reviews 2022; 6: CD013817

---

104834 Topical glaucoma medications - Clinical implications for the ocular surface
Fineide F
Ocular Surface 2022; 26: 19-49

---

104340 Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension
von Spreckelsen A
Cochrane Database of Systematic Reviews 2022; 6: CD013817

---

104834 Topical glaucoma medications - Clinical implications for the ocular surface
Lagali N; Adil MY
Ocular Surface 2022; 26: 19-49

---

104340 Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension
Kolko M
Cochrane Database of Systematic Reviews 2022; 6: CD013817

---

104834 Topical glaucoma medications - Clinical implications for the ocular surface
Arita R
Ocular Surface 2022; 26: 19-49

---

104340 Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension
Azuara-Blanco A
Cochrane Database of Systematic Reviews 2022; 6: CD013817

---

104834 Topical glaucoma medications - Clinical implications for the ocular surface
Kolko M
Ocular Surface 2022; 26: 19-49

---

104340 Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension
Virgili G
Cochrane Database of Systematic Reviews 2022; 6: CD013817

---

104834 Topical glaucoma medications - Clinical implications for the ocular surface
Vehof J; Utheim TP
Ocular Surface 2022; 26: 19-49

---